DiaSorin stock trades at EUR 77.96 before November 6 results
Published on 10/13/2026 at 14:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DiaSorin stock trades at EUR 77.96 before the company's scheduled third-quarter 2026 results on November 6, 2026. finanzen.net lists November 6, 2026 as the reporting date. At Lang & Schwarz, the stock was trading at EUR 77.96 on October 13, 2026 at 2:39 p.m. CEST, up 0.21 percent versus the Xetra close of October 12, 2026 at EUR 77.80.
November results set the next date
The November 6 date gives investors the next fixed checkpoint for DiaSorin's operating performance. The calendar lists an estimated third-quarter earnings-per-share figure of EUR 0.93, a consensus figure rather than a reported result, while the second-quarter 2026 results were dated July 31, 2026.
The most recent full-year figures shown on DiaSorin's investor page are for fiscal year 2025. Revenue was EUR 1,195 million, adjusted EBITDA was EUR 394 million, adjusted net profit was EUR 223 million and free cash flow was EUR 209 million, according to DiaSorin.
Stock remains near its yearly high
The current euro price sits within the 52-week range of EUR 52.34 to EUR 79.72 as of October 13, 2026. At EUR 77.96, the stock is 2.21 percent below the yearly high, leaving the upcoming results as the next quantified test of the valuation.
DiaSorin's market capitalization is EUR 3.8 billion as of October 13, 2026. The price-to-earnings ratio is 24.83 and the dividend yield is 1.89 percent, figures listed by finanzen.net for DiaSorin's EUR listing.
Trading context stays measurable
DiaSorin is listed on Borsa Italiana under the symbol DIA.MI, and Teleborsa identifies the company as a member of the FTSE Italia Mid Cap. Its October 12, 2026 closing level was EUR 77.80, which provides the Xetra comparison base for the current Lang & Schwarz quote.
The bid was EUR 77.90 and the ask was EUR 78.02 at Lang & Schwarz on October 13, 2026 at 2:39 p.m. CEST. The narrow EUR 0.12 spread places the immediate trading frame around the EUR 77.96 price, while the EUR 79.72 yearly high remains the next visible reference level.
What matters before November 6
For investors, the key comparison is between the estimated third-quarter earnings per share of EUR 0.93 and the fiscal year 2025 profitability base. The scheduled results will show whether the revenue and cash generation profile reported for fiscal year 2025 has carried into the latest quarter.
The further course of trading is shown by the continuously updated real-time quote of DiaSorin stock.
DiaSorin stock facts
- Company: DiaSorin S.p.A.
- ISIN: IT0003492391
- Ticker: DIA.MI
- Primary exchange: Borsa Italiana
- Price Lang & Schwarz (as of October 13, 2026, 2:39 p.m. CEST): EUR 77.96
- Change versus Xetra close: plus 0.21 percent
- Xetra close (October 12, 2026): EUR 77.80
- Market capitalization: EUR 3.8 billion (as of October 13, 2026)
- 52-week range: EUR 52.34-EUR 79.72 (as of October 13, 2026)
- Sector / Industry: Healthcare diagnostics
- Index membership: FTSE Italia Mid Cap
- Next earnings date: November 6, 2026
Market context: Market report FTSE MIB.
